Microvascular reperfusion during endovascular therapy: the balance of supply and demand.
Christopher G FavillaRodrigo M FortiSarah CarterW Andrew KofkeScott E KasnerWesley B BakerArjun G YodhSteven R MesséStephanie CummingsDavid K KungJan Karl BurkhardtBryan PukenasVisish M SrinivasanRobert W HurstJohn A DetrePublished in: Journal of neurointerventional surgery (2023)
CBF augmentation alone does not predict post-EVT outcomes, but when microvascular reperfusion closely matches the baseline CBF deficit, patients experience favorable clinical and radiographic outcomes. By recognizing inadequate reperfusion, bedside CBF monitoring may provide opportunities to personalize post-EVT care aimed at CBF optimization.
Keyphrases
- cerebral ischemia
- acute myocardial infarction
- end stage renal disease
- acute ischemic stroke
- healthcare
- ejection fraction
- newly diagnosed
- chronic kidney disease
- palliative care
- prognostic factors
- subarachnoid hemorrhage
- stem cells
- percutaneous coronary intervention
- mesenchymal stem cells
- brain injury
- coronary artery disease
- metabolic syndrome
- pain management
- quality improvement
- skeletal muscle
- bone marrow
- weight loss
- acute coronary syndrome
- soft tissue
- affordable care act
- patient reported